What is OptimizeRx's total equity?

OptimizeRx (OPRX) reported total equity of $129.61M in Q1 2026.

How has OptimizeRx's total equity changed year-over-year?

OptimizeRx's total equity increased by 11.5% year-over-year, from $116.27M to $129.61M.

What is the long-term trend for OptimizeRx's total equity?

Over 5 years (2020 to 2025), OptimizeRx's total equity has grown at a 20.8% compound annual growth rate (CAGR), from $49.97M to $128.29M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

OptimizeRx OPRX Total Equity

Total Equity at other companies

Veeva SystemsVEEV

$7.3B+17.6%

PhreesiaPHR

$359.09M+27.3%

DoximityDOCS

$950.84M-12.2%

GoodRx Holdings, Inc.GDRX

$621.99M-4.9%

PubMaticPUBM

$251M-8.9%

National Research CorporationNRC

$13.5M-54.5%

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's total equity?: OptimizeRx (OPRX) reported total equity of $129.61M in Q1 2026.
How has OptimizeRx's total equity changed year-over-year?: OptimizeRx's total equity increased by 11.5% year-over-year, from $116.27M to $129.61M.
What is the long-term trend for OptimizeRx's total equity?: Over 5 years (2020 to 2025), OptimizeRx's total equity has grown at a 20.8% compound annual growth rate (CAGR), from $49.97M to $128.29M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.